期刊
NATURE CELL BIOLOGY
卷 15, 期 3, 页码 284-294出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2690
关键词
-
类别
资金
- NIH [CA151541]
- S. G. Komen For The Cure Foundation [KG101633]
- American Cancer Society [RSG-10-157-01-LIB]
- Ministry of Science and Technology Key Program of China [2012ZX10002009-017]
- National Basic Research Program of China [2010CB912102]
The tumour stroma is an active participant during cancer progression. Stromal cells promote tumour progression and metastasis through multiple mechanisms including enhancing tumour invasiveness and angiogenesis, and suppressing immune surveillance. We report here that miR-126/miR-126*, a microRNA pair derived from a single precursor, independently suppress the sequential recruitment of mesenchymal stem cells and inflammatory monocytes into the tumour stroma to inhibit lung metastasis by breast tumour cells in a mouse xenograft model. miR-126/miR-126* directly inhibit stromal cell-derived factor-1 alpha (Sdf-1 alpha) expression, and indirectly suppress the expression of chemokine (C-C motif) ligand 2 (Ccl2) by cancer cells in an Sdf-1 alpha-dependent manner. miR-126/miR-126* expression is downregulated in cancer cells by promoter methylation of their host gene Egfl7. These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis, and demonstrate a correlation between miR-126/126* downregulation and poor metastasis-free survival of breast cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据